Literature DB >> 29611010

Expanded algorithm for managing patients with acute decompensated heart failure.

Joyce N Njoroge1, Baljash Cheema2, Andrew P Ambrosy3, Stephen J Greene3, Sean P Collins4, Muthiah Vaduganathan5, Alexandre Mebazaa6,7, Ovidiu Chioncel8,9, Javed Butler10, Mihai Gheorghiade2.   

Abstract

Heart failure is a complex disease process, the manifestation of various cardiac and noncardiac abnormalities. General treatment approaches for heart failure have remained the same over the past decades despite the advent of novel therapies and monitoring modalities. In the same vein, the readmission rates for heart failure patients remain high and portend a poor prognosis for morbidity and mortality. In this context, development and implementation of improved algorithms for assessing and treating HF patients during hospitalization remains an unmet need. We propose an expanded algorithm for both monitoring and treating patients admitted for acute decompensated heart failure with the goal to improve post-discharge outcomes and decrease rates of rehospitalizations.

Entities:  

Keywords:  Acute decompensated heart failure, rehospitalizations; HFrEF; Heart failure

Mesh:

Year:  2018        PMID: 29611010      PMCID: PMC6551605          DOI: 10.1007/s10741-018-9697-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  89 in total

1.  Acute heart failure: the role of focused emergency cardiopulmonary ultrasound in identification and early management.

Authors:  Robinson M Ferre; Ovidiu Chioncel; Peter S Pang; Roberto M Lang; Mihai Gheorghiade; Sean P Collins
Journal:  Eur J Heart Fail       Date:  2015-10-14       Impact factor: 15.534

2.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

Review 3.  Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Circulation       Date:  2006-05-23       Impact factor: 29.690

4.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure.

Authors:  L W Stevenson; J K Perloff
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

5.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

Authors:  William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav
Journal:  Lancet       Date:  2011-02-19       Impact factor: 79.321

Review 6.  The physiologic basis of diuretic synergism: its role in treating diuretic resistance.

Authors:  D H Ellison
Journal:  Ann Intern Med       Date:  1991-05-15       Impact factor: 25.391

7.  Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure.

Authors:  Julio Núñez; Miguel González; Gema Miñana; Rafael Garcia-Ramón; Juan Sanchis; Vicent Bodí; Eduardo Núñez; Maria Jesús Puchades; Patricia Palau; Pilar Merlos; Angel Llàcer; Alfonso Miguel
Journal:  Eur J Heart Fail       Date:  2012-02-09       Impact factor: 15.534

8.  Treatment of anemia with darbepoetin alfa in systolic heart failure.

Authors:  Karl Swedberg; James B Young; Inder S Anand; Sunfa Cheng; Akshay S Desai; Rafael Diaz; Aldo P Maggioni; John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Scott D Solomon; Yan Sun; Michal Tendera; Dirk J van Veldhuisen
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

9.  Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Authors:  Philip D Home; Stuart J Pocock; Henning Beck-Nielsen; Paula S Curtis; Ramon Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; John J V McMurray
Journal:  Lancet       Date:  2009-06-06       Impact factor: 79.321

10.  Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Authors:  Stephen J Greene; Mihai Gheorghiade; Muthiah Vaduganathan; Andrew P Ambrosy; Robert J Mentz; Haris Subacius; Aldo P Maggioni; Savina Nodari; Marvin A Konstam; Javed Butler; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2013-07-11       Impact factor: 15.534

View more
  4 in total

1.  Mihai Gheorghiade, MD-Life and Concepts.

Authors:  Peter S Pang; Sean P Collins; Javed Butler; Ovidiu Chioncel
Journal:  Am J Ther       Date:  2018 Jul/Aug       Impact factor: 2.688

2.  Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure.

Authors:  Rong Huang; Ziyan Wang; Jianzhou Chen; Xue Bao; Nanjiao Xu; Simin Guo; Rong Gu; Weimin Wang; Zhonghai Wei; Lian Wang
Journal:  Cardiovasc Diabetol       Date:  2022-05-31       Impact factor: 8.949

Review 3.  Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.

Authors:  Joyce N Njoroge; John R Teerlink
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

4.  Do we need a simplified model to predict outcomes in patients hospitalized with Acute Decompensated Heart Failure? Results from The Role of Sodium in Heart Failure Outcomes Prediction ('SHOUT-PREDICTION') study.

Authors:  Shishir Soni; Yashwant Panwar; Anil Bharani
Journal:  Indian Heart J       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.